慢性胆管炎伴间质黏液变性误诊为胆管癌1例报告

范松松; 张芳; 杨立鹏; 曹学峰; 卢艳敏; 张兴元

doi:10.3969/j.issn.1001-5256.2022.07.031

慢性胆管炎伴间质黏液变性误诊为胆管癌1例报告

DOI: 10.3969/j.issn.1001-5256.2022.07.031

a.
滨州医学院附属医院肝胆外科, 山东滨州 256600
b.
滨州医学院附属医院护理部, 山东滨州 256600
c.
滨州医学院附属医院临床营养支持中心, 山东滨州 256600

基金项目:

山东省自然科学基金项目 (ZR2015HL084)

伦理学声明：本报告已获得患者知情同意。

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：范松松、张芳、杨立鹏、曹学峰、卢艳敏、张兴元负责查阅文献并拟定写作思路; 范松松、张芳、杨立鹏、曹学峰负责资料分析; 范松松、张芳、张兴元负责论文写作与修改。

详细信息

通信作者:
张兴元，byfyzxy@163.com

计量
- 文章访问数: 768
- HTML全文浏览量: 232
- PDF下载量: 29
- 被引次数: 0
出版历程
- 收稿日期: 2021-09-02
- 录用日期: 2021-10-25
- 出版日期: 2022-07-20

Chronic cholangitis with interstitial mucinous degeneration misdiagnosed as cholangiocarcinoma: A case report

a.
Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China
b.
Department of Nursing, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China
c.
Clinical Nutrition Support Center, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China

Research funding:

Nature Science Foundation of Shandong Province (ZR2015HL084)

More Information

Corresponding author: ZHANG Xingyuan, byfyzxy@163.com(ORCID: 0000-0002-7405-3805)

摘要

- 胆管炎 /
- 间质黏液变性 /
- 胆管肿瘤 /
- 误诊
- Cholangitis /
- Interstitial Mucinous Degeneration /
- Bile Duct Neoplasms /
- Diagnostic Errors

HTML全文

图 1 影像学检查

注：a，CT提示肝总管、胆囊管及胆总管交界区偏心性增厚伴近端胆管扩张; b，MRCP表现为肝总管、胆囊管及胆总管交界区狭窄，梗阻近端胆系扩张。

Figure 1. Image analysis

下载: 全尺寸图片幻灯片

图 2 HE染色及免疫组化结果(×200)

注：a，HE染色提示慢性胆管炎伴间质黏液变性; b，免疫组化分析示CD68(+); c，免疫组化分析示CD20(+); d，免疫组化分析示CD3(+)。

Figure 2. HE staining and immunohistochemistry(×200)

下载: 全尺寸图片幻灯片

参考文献(22)

[1]	RIZVI S, KHAN SA, HALLEMEIER CL, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2): 95-111. DOI: 10.1038/nrclinonc.2017.157.
[2]	GAO B, ZHAO HY. Progress in the epidemiological characteristics and risk factors of intrahepatic cholangiocarcinoma[J]. J Mod Oncol, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037. 高博, 赵海鹰. 肝内胆管癌的流行病学特征及危险因素研究进展[J]. 现代肿瘤医学, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037.
[3]	KHAN SA, TAVOLARI S, BRANDI G. Cholangiocarcinoma: Epidemiology and risk factors[J]. Liver Int, 2019, 39(Suppl 1): 19-31. DOI: 10.1111/liv.14095.
[4]	SCHIZAS D, MASTORAKI A, ROUTSI E, et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(6): 515-523. DOI: 10.1016/j.hbpd.2020.07.004.
[5]	PU T, FANG Q, CHEN ZX, et al. Advances in molecular pathogenesis and treatment of intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325. 濮天, 方强, 陈子祥, 等. 肝内胆管癌发病机制及治疗相关进展[J]. 中华消化外科杂志, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325.
[6]	SHEN H, XIA Y, CHEN YB, et al. Risk factors analysis of intrahepatic cholangiocarcinoma after hepatectomy for hepatolithiasis[J]. Chin J Dig Surg, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402. 沈皓, 夏勇, 陈玉宝, 等. 肝内胆管结石肝切除术后发生肝内胆管癌的危险因素分析[J]. 中华消化外科杂志, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402.
[7]	LI L, LIU H, SONG WY. Analysis of the clinical characteristics and diagnosis and treatment process of IgG4-related sclerosing cholangitis[J]. J Clin Hepatol, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026. 李丽, 刘晖, 宋文艳. IgG4相关硬化性胆管炎临床特征及诊疗过程分析[J]. 临床肝胆病杂志, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.
[8]	RIZVI S, GORES GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6): 1215-1229. DOI: 10.1053/j.gastro.2013.10.013.
[9]	DOHERTY B, NAMBUDIRI VE, PALMER WC. Update on the diagnosis and treatment of cholangiocarcinoma[J]. Curr Gastroenterol Rep, 2017, 19(1): 2. DOI: 10.1007/s11894-017-0542-4.
[10]	MA WJ, SHRESTHA A, LI FY. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?[J]. Cancer Med, 2016, 5(10): 2848-2849. DOI: 10.1002/cam4.920.
[11]	MACIAS R, KORNEK M, RODRIGUES PM, et al. Diagnostic and prognostic biomarkers in cholangiocarcinoma[J]. Liver Int, 2019, 39(Suppl 1): 108-122. DOI: 10.1111/liv.14090.
[12]	WANG TL, WU G. Progress in diagnosis and treatment of IgG4 associated sclerosing cholangitis[J]. Chin J Gerontol, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063. 王天龙, 吴刚. IgG4相关硬化性胆管炎的诊治进展[J]. 中国老年学杂志, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063.
[13]	XIAO J, LI G, YANG G, et al. Case report: A female case of isolated IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma[J]. Medicine(Baltimore), 2017, 96(16): e6542. DOI: 10.1097/MD.0000000000006542.
[14]	TANAKA A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis[J]. Gut Liver, 2019, 13(3): 300-307. DOI: 10.5009/gnl18085.
[15]	LLEO A, MARZORATI S, ANAYA JM, et al. Primary biliary cholangitis: a comprehensive overview[J]. Hepatol Int, 2017, 11(6): 485-499. DOI: 10.1007/s12072-017-9830-1.
[16]	NGUYEN CANH H, HARADA K. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma[J]. Med Mol Morphol, 2016, 49(4): 189-202. DOI: 10.1007/s00795-016-0143-6.
[17]	MA MX, JAYASEKERAN V, CHONG AK. Benign biliary strictures: Prevalence, impact, and management strategies[J]. Clin Exp Gastroenterol, 2019, 12: 83-92. DOI: 10.2147/CEG.S165016.
[18]	LIANG BY, HUANG ZY, ZHANG ZY, et al. Etiology, diagnosis and treatment of benign hepatic portal biliary stenosis[J]. J Abdom Surg, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003. 梁宾勇, 黄志勇, 张尊义, 等. 肝门部胆管良性狭窄的病因、诊断及治疗[J]. 腹部外科, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003.
[19]	TANG ZW, MENG WB, LI X. Status and controversy of preoperative diagnosis and bile duct cholangiocarcinoma drainage strategy[J]. J Lanzhou Univ, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012. 唐增伟, 孟文勃, 李汛. 肝门部胆管癌术前诊断及胆道引流策略的现状与争议[J]. 兰州大学学报, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012.
[20]	XU W, MIAO L, WANG ZF, et, al. Application of SpyGlass TM DS in diagnosis and treatment of biliary diseases[J]. J Clin Hepatol, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052. 徐雯, 苗龙, 王正峰, 等. SpyGlass TM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.
[21]	ZHANG GJ, ZHANG DY, CAI FC, et al. New development of endoscopic retrograde cholangiopancreatography in the diagnosis and treatment[J/CD]. Chin J Gastrointestinal Endosc(Electronic Edition), 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008. 张贯军, 张大涯, 蔡逢春, 等. 内镜逆行胰胆管造影术诊治新进展[J/CD]. 中华胃肠内镜电子杂志, 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008.
[22]	TAGHAVI SA, ESHRAGHIAN A, NIKNAM R, et al. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(6): 575-584. DOI: 10.1080/17474124.2018.1473761.